ID: ALA3733336

Max Phase: Preclinical

Molecular Formula: C22H26BrNS

Molecular Weight: 416.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=C(C)C[C@H]1[C@H]2c3c(Br)cccc3[C@H](CC2(C)C)N1Cc1ccsc1

Standard InChI:  InChI=1S/C22H26BrNS/c1-14(2)10-18-21-20-16(6-5-7-17(20)23)19(11-22(21,3)4)24(18)12-15-8-9-25-13-15/h5-9,13,18-19,21H,1,10-12H2,2-4H3/t18-,19-,21-/m0/s1

Standard InChI Key:  NMUFGVINDAIMKX-ZJOUEHCJSA-N

Associated Targets(Human)

CYBB Tchem Cytochrome b-245 heavy chain (193 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NOX4 Tchem NADPH oxidase 4 (333 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NOX1 Tchem NADPH oxidase 1 (291 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NOX5 Tchem NADPH oxidase 5 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

XDH Xanthine dehydrogenase (2296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 416.43Molecular Weight (Monoisotopic): 415.0969AlogP: 6.92#Rotatable Bonds: 4
Polar Surface Area: 3.24Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.93CX LogP: 6.53CX LogD: 5.89
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.49Np Likeness Score: -0.40

References

1.  (2014)  Tetrahydroisoquinolines as selective nadph oxidase 2 inhibitors, 

Source